HSDD Prevalence
Examine the prevalence of female sexual problems associated with distress in premenopausal women

The prevalence of hypoactive
sexual desire disorder (HSDD)

HSDD may be more common than you think

According to PRESIDE, a survey of 31,581 women stratified into 3 age groups (18-44 years [n=12,959], 45-64 years [n=11,900], and ≥65 years [n=6338])*1

Prevalence of female sexual problems associated with distress†1

Prevalence of female sexual problems associated with distress Prevalence of female sexual problems associated with distress
HSDD is the most prevalent female sexual dysfunction. HSDD is the most prevalent female sexual dysfunction.

HSDD has affected approximately 1 in 10 premenopausal women in the United States‡1

 
 

PRESIDE=Prevalence of Female Sexual Problems Associated with Distress and Determinants of Treatment.

*PRESIDE is a cross-sectional, population based survey of female adults in the United States. The purpose was to estimate the prevalence of self-reported sexual problems of desire, arousal, and orgasm, the prevalence of sexually related personal distress, and their combination, and to identify associated factors.

The numbers depicted are US population age-adjusted estimates.

Based on women aged 18 to 44 years in the PRESIDE population (n=12,959).

HSDD: a common condition

HSDD is prevalent1

Sharon J. Parish, MD, Weill Cornell Medical College, discusses the prevalence and burden of HSDD.
Sharon J. Parish, MD, IF, NCMP
Weill Cornell Medical College

Dr. Parish is a consultant for AMAG Pharmaceuticals, Inc. and Palatin Technologies, Inc.

Explore the burden of HSDD

 

Join the Conversation

REGISTER TODAY!

It’s too important to miss,
and there’s a lot to talk about.

Register for Email updates and more.


References: 1. Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol. 2008;112(5):970‐978. 2. Goldstein I, Kim NN, Clayton AH, et al. Hypoactive sexual desire disorder: International Society for the Study of Women’s Sexual Health (ISSWSH) expert consensus panel review. Mayo Clin Proc. 2017;92(1):114‐128.

References Back to Top

Thank you for registering at AMAG Pharmaceuticals, Inc.



Let’s talk about hypoactive sexual desire disorder (HSDD).